Innovation

Integrated CMOS Capacitance Sensors for On-Chip Tracking of Cell Proliferation

University of Maryland
posted on 08/06/2009

Researchers at the University of Maryland have developed a novel miniaturized technique in which CMOS capacitance sensors track cell proliferation by measuring the capacitive coupling between on-chip sensing electrodes and the cellular matrix.


Innovation Details
 

Detailed Description


Quantifying cell growth is essential for many applications in cell biology and biotechnology. It is required for optimizing cell culture conditions, for studying substances that inhibit or promote cell growth, for studying cancer progression, cytotoxicity assessment, biocompatibility characterization, etc. Traditional cell proliferation assays are label-based endpoint assays that require sample preparation and sophisticated lab equipment. An example of an alternative, label-free technique that is being currently employed for automating cell proliferation studies is electric cell-substrate impedance sending (ECIS). However, ECIS still requires external measurement instruments such as lock-in amplifiers and impedance analyzers.

Researchers at the University of Maryland have developed a novel miniaturized technique in which CMOS capacitance sensors are employed to measure the capacitive coupling between on-chip sensing electrodes and the cellular matrix cultured on them, as a means of tracking cell proliferation. The electrodes are arranged in a planar configuration within the growth chamber and are insulated from the cell environment in order to prevent electrochemical side-effects associated with exposed electrodes. This approach is completely electronic, does not require any sample preparation or biochemical labeling, and allows for online monitoring, experimental automation, and high speed analysis. The sensor chip is designed and fabricated using conventional CMOS technology. There is no required post-processing of the chip, except for a biocompatible packaging step. The integrated capacitance sensing platform offers an easy-to-use, portable and cost-effective solution for tracking cell proliferation in vitro, without requiring extensive laboratory infrastructure.

File Number: PS-2008-047 

Disease: Cancer


IP Protection


License Online

This innovation currently is not available for online licensing. Please contact the case manager at University of Maryland for more information.

Request more info via email request more info
People

No people are currently associated with this innovation.


Download Technology Brief (PDF)


Followed By

Follow this innovation



No one is following this innovation.

Organization
Profile
Related Tags

Find more innovations


February 11, 2009

7,868 members 17,196 innovations 152 organizations

Browse

William Garner, M.D., MPH - CEO of Urigen, N.A., Inc.

"The iBridge Network provides an important additional pathway for entrepreneurs to access university innovations that may otherwise have been lost. The transparency of this pathway between entrepreneurs..."  read more...